Clear Proof Blemish Control Toner

Description

Clearproof Blemish Control Toner is an acne medication formulated with 2% salicylic acid. This liquid dosage form is designed to assist in the management of acne. Each container holds 5 fluid ounces (147 mL) of the product and is manufactured by Mary Kay.

Uses and Indications

This drug is indicated for the management of acne. It assists in preventing the formation of new acne pimples.

There are no teratogenic or nonteratogenic effects mentioned associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This should be done one to three times daily, depending on the patient's needs and the physician's guidance.

To minimize the risk of excessive drying of the skin, it is advisable to initiate treatment with one application per day. Based on the patient's response and tolerance, the frequency may be gradually increased to two or three times daily as necessary or as directed by a healthcare provider.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once daily or every other day to alleviate these side effects.

Contraindications

Use is contraindicated in patients who experience irritation or sensitivity that develops or increases during treatment. Additionally, contact with the eyes should be avoided to prevent potential adverse effects.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid concurrent use of this product with other topical acne medications, as this may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended to limit the use to one topical acne medication at a time.

Contact with the eyes should be strictly avoided. In cases where irritation or sensitivity develops or worsens, patients should discontinue use immediately and consult a healthcare provider for further guidance.

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients using this product may experience adverse reactions, primarily skin irritation and dryness, particularly when used concurrently with other topical acne medications. The likelihood of these reactions increases with simultaneous use of multiple topical agents. It is advised that patients limit the use of topical acne medications to one at a time to minimize the risk of irritation.

In addition, patients should avoid contact with the eyes to prevent potential adverse effects. If any irritation or sensitivity develops or worsens, patients are instructed to discontinue use and consult a healthcare professional for further guidance.

This product is intended for external use only, and adherence to these precautions is essential to ensure patient safety and efficacy of treatment.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Clear Proof Blemish Control Toner (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

When using this product, the likelihood of skin irritation and dryness increases if another topical acne medication is used concurrently. To minimize the risk of irritation, it is advised that only one topical acne medication be applied at a time. Should bothersome dryness or peeling occur, the frequency of application should be reduced to once daily or every other day.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of Clear Proof Blemish Control Toner during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering its use in pregnant patients. Healthcare professionals are advised to exercise caution and consider the absence of data when discussing the use of this product with women of childbearing potential.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific contraindications. However, as with any medication, the benefits and risks should be assessed on a case-by-case basis.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no available information regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management procedures.

Healthcare providers should ensure that patients are monitored closely for any signs of toxicity and that supportive care is initiated as necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience any irritation or sensitivity that develops or worsens during treatment. It is important to note that the likelihood of skin irritation and dryness may increase if patients use another topical acne medication concurrently. Therefore, healthcare providers should recommend that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, patients should be cautioned to avoid contact with the eyes, as this may lead to adverse effects.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The bottle should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically and is intended for external use only. Patients should be advised that using this product concurrently with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event of irritation, it is recommended to limit use to one topical acne medication at a time. Clinicians should instruct patients to avoid contact with the eyes and to discontinue use if irritation or sensitivity develops or worsens. Additionally, the product should be kept out of reach of children, and immediate medical assistance should be sought if ingested.

Drug Information (PDF)

This file contains official product information for Clear Proof Blemish Control Toner, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)